Identification | Back Directory | [Name]
tert-butyl 3-carbaMoylazetidine-1-carboxylat | [CAS]
486415-29-6 | [Synonyms]
N-Boc-azetidine-3-carboxamide 1-Boc-azetidine-3-carboxamide tert-butyl 3-carbaMoylazetidine-1-carboxylat 3-Carbamoyl-azetidine-1-carboxylic acid tert-butyl ester 1-Azetidinecarboxylic acid, 3-(aminocarbonyl)-, 1,1-dimethylethyl ester | [Molecular Formula]
C9H16N2O3 | [MDL Number]
MFCD11975575 | [MOL File]
486415-29-6.mol | [Molecular Weight]
200.23 |
Chemical Properties | Back Directory | [Boiling point ]
355.9±31.0 °C(Predicted) | [density ]
1.194±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [pka]
16.06±0.20(Predicted) | [Appearance]
White to off-white Solid |
Hazard Information | Back Directory | [Synthesis]
General procedure for the synthesis of N-Boc-azetidine-3-carboxamide from 1-Boc-azetidine-3-carboxylic acid: 1-[(tert-butoxy)carbonyl]azetidine-3-carboxylic acid (4.96 g, 24.65 mmol) and triethylamine (TEA, 5.84 mL, 42.0 mmol) were dissolved in tetrahydrofuran (THF, 60 mL) and the the mixture was cooled to -20 °C. Isobutyl chloroformate (4.8 mL, 37.0 mmol) was added slowly with stirring, followed by stirring the reaction mixture at -10 °C for 15 min. 28% ammonia (7.46 mL, 394 mmol) was added, then the mixture was gradually warmed to room temperature and stirring was continued for 1 hour. Upon completion of the reaction, the reaction was quenched with saturated sodium bicarbonate (NaHCO?) solution, the reaction mixture was filtered and concentrated under reduced pressure. The crude product was purified by fast column chromatography using 20-100% ethyl acetate (EtOAc)/heptane gradient elution and 1-4% methanol (MeOH)/ethyl acetate (EtOAc) elution sequentially to afford N-Boc-azetidine-3-carboxamide (3.99 g, 81% yield) as a white solid. The product was confirmed by 1H-NMR (CDCl?, 250 MHz) and HPLC-MS (Method A): 1H-NMR δ [ppm] = 5.47 (s, 2H), 4.22-4.01 (m, 4H), 3.34-3.15 (m, 1H), 1.46 (s, 9H); HPLC-MS [m/z]: 222.95 [M + Na ]+. | [References]
[1] Patent: WO2017/68089, 2017, A2. Location in patent: Page/Page column 234; 235 [2] Patent: US2014/121198, 2014, A1. Location in patent: Paragraph 0688; 0689 [3] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 5, p. 757 - 761 [4] Patent: WO2010/60952, 2010, A1. Location in patent: Page/Page column 81 [5] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 10, p. 3037 - 3040 |
|
Company Name: |
Tetranov Biopharm
|
Tel: |
13526569071 |
Website: |
http://www.leadmedpharm.com/index.html |
Company Name: |
Struchem Co., Ltd.
|
Tel: |
0512-63009836 18994340901 |
Website: |
www.beidapharma.com |
|